Gateshead & South Tyneside LPC  
  • Maintenance
  • Events
  • Contact Us

MHRA issues precautionary recall of medicines

11/7/2013

0 Comments

 
Picture
The MHRA has issued class 2 drug alerts for Wockhardt and Pinewood Laboratories following manufacturing site inspections.

Pharmacies will need to take action within the next 48 hours and should note the large number of products  affected this time. 

16 different prescription only medicines in a variety of strengths made by Wockhardt Ltd  are affected following manufacturing deficiencies identified by the MHRA at Wockhardt’s Waluj site in India.

The medicines affected by the precautionary recall include those used for the treatment of infections, high blood pressure, diabetes, epilepsy, depression, schizophrenia, Parkinson’s disease, dementia in Alzheimer’s patients and thyroid conditions.

Full Details of the recalls 

1. Class 2 Drug Alert (Action within 48 Hours): Multiple products - Wockhardt UK Limited (EL (13)A/19) - This includes a list of all the medicines that are affected by the precautionary recall.

2. Class 2 Medicines recall (Action within 48 Hours): Erythromycin Oral Suspension - Pinewood Laboratories Limited (EL (13)A/20)

Patients do not need to return their medicines because there is no evidence that the medicines affected by the precautionary recall in the UK are defective. Therefore, it’s important that people continue to take their medicines as prescribed.

This is not a patient level recall because although the medicines that are affected have not been manufactured to Good Manufacturing Practice (GMP) standards, there is no evidence of a patient safety risk from medicines that have been sold in the UK. However, the MHRA has to act in the interests of public health as poor manufacturing standards cannot be allowed to continue.

The deficiencies identified by the MHRA during a routine inspection in March included a low risk of cross-contamination because of poor cleaning practices and defects in building fabric and the ventilation systems at the site. There was also evidence of forged documents relating to staff training records that had been rewritten. The MHRA is working with Wockhardt and other international regulators to resolve these issues.

Gerald Heddell, the MHRA’s Director of Inspection, Enforcement and Standards, said:

“This is a precautionary recall. People can be reassured that there is no evidence that medicines made by Wockhardt are defective so it’s important people continue to take their medicines as prescribed.  

“All batches of medicines manufactured outside the European Union are tested on importation to the UK before they reach patients. However, we have taken this precautionary action because the medicines have not been manufactured to the right regulatory standards.

“We are working with the Department of Health to ensure that people have access to the medicines they need. Anyone who has questions should speak to their pharmacist or GP.”

The medicines that are involved in the recall are available for patients from alternative manufacturers in most cases, either in equivalent strengths or varying strengths. Where there are no alternative manufacturers of the same medicines, substitutes are available and these should be selected by a healthcare professional.

The Department of Health is working closely with the companies concerned to help ensure that patients are able to get their medicines when they need them.


0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    News Stream

    This is our News Stream.  Any News stories that appear on our website will be archived here for your convenience in Chronological Order with Catogery  tags to help you find items you are looking for.   

    You can also use our search bar  to find items and our RSS feed on this page to keep informed of news. 

    RSS Feed


    LPC Newsletter Archive

    Copies of our older Paper Based News Letters (The LPC News) can be found by clicking below.

    Picture
    LPC News Letter Archive

    Archives

    November 2022
    October 2022
    August 2022
    July 2022
    June 2022
    May 2022
    March 2022
    January 2022
    September 2021
    August 2021
    July 2021
    June 2021
    April 2021
    March 2021
    January 2021
    December 2020
    October 2020
    September 2020
    August 2020
    February 2020
    January 2020
    December 2019
    October 2019
    July 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    March 2018
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012

    Categories

    All
    Action
    Alert
    Announcement
    Business
    Call To Action
    Campaign
    Category M
    Cd's
    Christmas
    Commisioning
    Concessions
    Consultation
    Contractual
    Controlled Drugs
    Council
    Cpaf
    Cpd
    Delivery
    Diabetes
    Drug Tariff
    Ehc
    Election
    Essential Services
    Event
    Finance
    First Contact Clinical
    Flu
    Funding
    Future
    Gateshead
    Gphc
    Guidance
    Health Checks
    Healthy Living Pharmacy
    HMRC
    Hope Winch
    Info
    Information Governance Ig
    INR
    Inspection
    IT
    Lecture
    Legislation
    Local Policy
    Lpn
    Lrc
    Medicines-management
    Meeting
    Mental Capacity Act
    Mental Health
    Mhra
    Mur
    Needle Exchange
    Nhs
    Nhs Contacts
    NHS Mail
    Nms
    North East Pharmacy Forum
    Palliative Care
    Payments
    Pharmacy Qualifications
    Politics
    Pre - Reg
    Prescription Charge
    Psnc
    Public Health
    Reacll
    Recall
    Resources
    RPS
    RPS Event
    Services
    Sexual Health
    Shared Care
    Smoking Cessation
    Standards
    Structure
    Students
    Substance Misuse
    Sunderland Uni
    Tax
    Training
    Up To Date
    Urgent Care
    Vaping

    RSS Feed

Gateshead & South Tyneside Local Pharmaceutical Committee 2016


Photos used under Creative Commons from USCPSC, GovInslee, NHSE, weisserstier, mjtmail (tiggy), RambergMediaImages, Brett Jordan